Share chart Viatris
Extended chart
Simple chart
About Viatris
Mylan N.V. была глобальной компанией по производству дженериков и специализированных фармацевтических препаратов, базирующейся в Нидерландах, с главными исполнительными офисами в Хатфилде, Хартфордшир, Великобритания, и «Глобальным центром» в Канонсбурге, Пенсильвания, США.Main settings
IPO date
2020-11-16
ISIN
US92556V1061
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
5.46
Дивиденд ао
0.12
Сайт
Grade
Underestimation
Title | Value | Grade |
P/S | 1 | 9 |
P/BV | 0.7927 | 9 |
P/E | 234.98 | 1 |
Efficiency
Title | Value | Grade |
ROA | -1.42 | 0 |
ROE | -3.24 | 0 |
ROIC | 1.21 | 1 |
Dividends
Title | Value | Grade |
Dividend yield | 4.58 | 10 |
DSI | 1 | 10 |
Average dividend growth | 20.64 | 10 |
Debt
Title | Value | Grade |
Debt/EBITDA | 5.07 | 0 |
Debt/Ratio | 0.3447 | 10 |
Debt/Equity | 1.23 | 8 |
Growth impulse
Title | Value | Grade |
Yield Revenue, % | 23.38 | 4 |
Yield Ebitda, % | 41.5 | 6 |
Yield EPS, % | -52.12 | 0 |
Dividends
Prices
Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
Yesterday | 9.26 $ | 0 $ | 0 $ | -0.324 % | 0 % | 0 % |
Week | 9.18 $ | 0 $ | 0 $ | +0.5447 % | 0 % | 0 % |
Month | 8.71 $ | 8.85 $ | 9.34 $ | +5.97 % | 0 % | 0 % |
Three month | 8.13 $ | 7.57 $ | 9.34 $ | +13.53 % | 0 % | 0 % |
Half a year | 11.25 $ | 7.26 $ | 11.48 $ | -17.96 % | 0 % | 0 % |
Year | 11.9 $ | 7.26 $ | 13.37 $ | -22.44 % | 0 % | 0 % |
3 years | 8.73 $ | 7.26 $ | 13.53 $ | +5.73 % | 0 % | 0 % |
5 years | 13.97 $ | 7.26 $ | 18.74 $ | -33.93 % | 0 % | 0 % |
10 years | 45.34 $ | 7.26 $ | 66.56 $ | -79.64 % | 0 % | 0 % |
Year to date | 10.73 $ | 7.26 $ | 12.42 $ | -13.98 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
Future Tech ETF | 1.32059 | 479.5 | 0.35 |
Principal Healthcare Innovators ETF | 1.32059 | -3.92 | 0.35 |
iShares Morningstar Mid-Cap ETF | 0.12712 | 245.03 | 0.04 |
iShares Morningstar Large-Cap Value ETF | 0.0532 | 51.43 | 0.25 |
iShares Morningstar Large-Cap ETF | 0.02755 | 186.3 | 0.03 |
Columbia U.S. ESG Equity Income ETF | 0.02437 | -4.51 | 0.35 |
0.48 | 158.97 | 0.23 |
---|
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
Mr. Paul B. Campbell | Chief Accounting Officer, Senior VP & Corporate Controller | N/A | 1968 (57 years) |
Mr. Scott Andrew Smith | CEO & Director | N/A | 1962 (63 years) |
Ms. Theodora Mistras | Chief Financial Officer | N/A | 1982 (43 years) |
Mr. Brian S. Roman | Chief Legal Officer | 1971 (54 years) | |
Mr. Ramkumar V. Rayapureddy | Chief Information Officer | ||
Mr. Andrew Enrietti | Chief People Officer | ||
Mr. Menassie Taddese M.B.A. | President of Emerging Markets | 1970 (55 years) | |
Mr. Derek Glover | Chief Quality Officer | ||
Ms. Lara Ramsburg | Chief Corporate Affairs Officer | ||
Dr. Jeffrey Nau MMS, Ph.D. | President of Viatris Eye Care Division | 1976 (49 years) |
About company
Address: United States, Canonsburg. PA, 1000 Mylan Boulevard - Open in google maps, Open in yandex maps
Website: https://www.viatris.com
Website: https://www.viatris.com